The California Alpha-Fetoprotein Screening Program: An Advocacy Program for Handicapped Children

Crandall BF , Robertson RD , Lebherz TB , King W. , Schroth PC “Maternal serum alpha-fetoprotein screening for the detection of neural tube defects.” Western Journal of Medicine, 138: 524–529, 1983.

Wetherall RC “Emergency regulations for filing,” R-93-94, NTD Reporting. October 9, 1985.

Zoler ML “Genetic testing creating a deluge of dilemmas.” Medical World News, p. 48, Sept. 22, 1986.

ACOG Technical Bulletin, #67, October, 1982.

Council of Scientific Affairs, “Maternal serum alpha-fetoprotein monitoring,” Journal of the American Medical Association, 247: 1478–1482, 1982.

“Prevention 1990: California's Future,” Department of Developmental Services, DHS, p. 41, Aug, 30, 1984.

Crandall BF “Prevention 1990: California's Future,” Department of Developmental Services, DHS, p. 526.

Kave CI MD, PhD, at the Cook County Graduate School of Medicine, Chicago, April 30, 1986.

Myhre Carolyn personal communication. Coordinator, the San Diego-Imperial Counties Regional Center, The California Alpha-Fetoprotein Screening Program. Sept 15, 1986.

Cuckle H. , Wald N. “Report of UK Collaborative Study on alpha-fetoprotein in relation to neural tube defects,” Lancet, 1: 1332, 1977.

Milunsky A , Alpert E. “Results and benefits of a maternal serum alpha-fetoprotein screening program,” JAMA, 252: 1438, 1984.

Stillman PC , Hoffman JK . “AFP anxiety,” California Physician, 145: 393, 1986.

Koop CE Statement. Public Relations Office of the Surgeon General of the United States, June 12, 1986.

Marwick C. “Controversy surrounds use of test for open spina bifida,” JAMA, 250: 576, 1983.

Marwick C. “Controversy surrounds use of test for open spina bifida,” JAMA, 250: p. 577.

Simpson JL . “Genetics for the practicing physician.” ACOG Advances in Obstetrics and Gynecology, 1 (5601): 56. 1985.

Simpson JL . “Genetics for the practicing physician.” ACOG Advances in Obstetrics and Gynecology, 1 (5601), p. 62.

Stark GD . Spina Bifida: Problems and Management, (London: Black well Scientific Publications. 1977), pp. 6. 7. 17.

Martin LW , Torres AM . “Omphalocele and gastrochesis.” The Surgical Clinics of North America, 65: 1235, 1985.

Simpson JL . op. cit.

Mahour GH . “Omphalocele.” Surgery. Gynecology and Obstetrics, 143: 822, 1976.

Wald NJ. , Cuckle HS. “Early antenatal diagnosis of exomphalos.” Lancet, 1: 1368, 1980.

Martin LW . op. cit., p. 1243.

Simpson JL . Genetics. Council of Residency Education in Obstetrics and Gynecology, Washington, D.C., 1986, p. 43.

Macri JN . “Critical issues in prenatal maternal serum alpha-fetoprotein screening for genetic anomalies.” American Journal of Obstetrics and Gynecology, 155: 245, 1986.

Myhre C. op, cit.

Prevention 1990: California's Future, op. cit., p. 43.

Advisory Medi-Cal Computer Science Corporation. 1986.

Hastings Center Report, 15: 18, 1985.

Marimon P. Sequelae of induced abortion. 1984.

Berkowitz RL . in ACOG Update: Alpha-fetoprotein. 10: 2. 1984.

Hastings Center Report, op. cit.

Kizer KW . Notice of public hearing on emergency regulationsof the Dept of Health Services regarding NTD reporting. DHS, pp. 1–2. Oct. 7, 1985.

Cunningham G. Fiscal Impact Analysis. December. 1985.

Statement of Informed Consent Refusal for Alpha-Fetoprotein Screening, in Prenatal Screening Tests for Neural Tube and Other Birth Defects. Genetic Disease Branch, DHS. 1986.